Attributable burden of hospital-onset Clostridium difficile infection: A propensity score matching study

Infection Control and Hospital Epidemiology

Volumn 34, Issue 6, 2013, Pages 588-596

  Tabak, Ying P ^a   Zilberberg, Marya D ^b   Johannes, Richard S ^a,c   Sun, Xiaowu ^a   Mcdonald, L Clifford ^d  

^a Clinical Research Department   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; BOOTSTRAPPING; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; COST OF ILLNESS; DESCRIPTIVE RESEARCH; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INFECTIOUS DIARRHEA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PROPENSITY SCORE; RISK FACTOR;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PENNSYLVANIA; PROPENSITY SCORE;

EID: 84877647833     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/670621     Document Type: Article

References (30)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160-166.
2. Roberts RR, Scott RD II, Hota B, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010;48(11):1026-1035.
3. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009. Statistical brief 124. Rockville, MD: Healthcare Cost and Utilization Project Statistical Briefs, 2012.
4. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30(1):57-66.
5. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34(3):346-353.
6. Dubberke ER, Butler AM, Reske KA, et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14(7):1031-1038.
7. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46(4):497-504.
8. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28(11):1219-1227.
9. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50(2):194-201.
10. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007;28(2):123-130.
11. Kilgore ML, Ghosh K, Beavers CM, Wong DY, Hymel PA Jr, Brossette SE. The costs of nosocomial infections. Med Care 2008; 46(1):101-104.
12. Zilberberg MD, Tabak YP, Sievert DM, et al. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011; 32(7):649-655.
13. Tabak YP, Johannes RS, Silber JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care 2007;45(8):789-805.
14. Tabak YP, Sun X, Derby KG, Kurtz SG, Johannes RS. Development and validation of a disease-specific risk adjustment system using automated clinical data. Health Serv Res 2010;45: 1815-1835.
15. Acute inpatient PPS. Centers for Medicare and Medicaid Services website. http://www.cms.hhs.gov/AcuteInpatientPPS/HIF/list.asp#TopOfPage. Accessed November 7, 2011.
16. Parsons LS, ed. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the 26th Annual SAS Users Group International Conference. Long Beach, CA: SAS Institute, 2001.
17. Austin PC. Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reduc-tions in propensity-score matched samples. Stat Med 2011; 30(11):1292-1301.
18. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott-Wolters-Kluwer, 2008.
19. Sato T. On the variance estimator for the Mantel-Haenszel risk difference. Biometrics 1989;45:1323-1324.
20. Sullivan LM, Dukes KA, Losina E. Tutorial in biostatistics: an introduction to hierarchical linear modelling. Stat Med 1999; 18(7):855-888.
21. Efron B, Tibshirani R. An Introduction to the Bootstrap. London: Chapman & Hall, 1993.
22. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010;31(3):262-268.
23. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clos-tridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235(3):363-372.
24. Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002;23(3):137-140.
25. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353(23):2442-2449.
26. Pepin J, Valiquette L, Cossette B. Mortality attributable to nos-ocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173(9):1037-1042.
27. Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ 2012;184(1):37-42.
28. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
29. Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61(9):157-162.
30. Centers for Medicare and Medicaid Services. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules. Fed Regist 2011; 76(160):51476-51843.